Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 1631 entries
View as:

EPID Multiple Sclerosis Pregnancy Study

Phase: N/A Priority: Normal
NCT ID: NCT02749396 Org: User:
Start: 05/02/16 End: 08/14/18 Due: 08/14/19

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

Phase: N/A Priority: Normal
NCT ID: NCT01706055 Org: User:
Start: 09/30/12 End: 03/31/16 Due: 03/31/17

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Phase: N/A Priority: Normal
NCT ID: NCT05794906 Org: User:
Start: 04/03/23 End: 03/29/30 Due: 03/29/31

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Phase: N/A Priority: Normal
NCT ID: NCT04521361 Org: User:
Start: 11/16/20 End: 09/01/25 Due: 09/01/26

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05614102 Org: User:
Start: 11/04/22 End: 06/07/27 Due: 06/07/28

REALIsM-HF Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03507439 Org: User:
Start: 04/06/18 End: 03/12/21 Due: 03/12/22

Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

Phase: N/A Priority: Normal
NCT ID: NCT04519619 Org: User:
Start: 11/27/20 End: 06/30/28 Due: 06/30/29

A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)

Phase: N/A Priority: Normal
NCT ID: NCT05705258 Org: User:
Start: 03/27/23 End: 03/30/27 Due: 03/30/28

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02661438 Org: User:
Start: 01/12/16 End: 03/17/16 Due: 03/17/17

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

Phase: N/A Priority: Normal
NCT ID: NCT00586521 Org: User:
Start: 02/28/06 End: 03/31/08 Due: 03/31/09

Sun Protection Factor Assay (SPF Assay 19009)

Phase: N/A Priority: Normal
NCT ID: NCT02815228 Org: User:
Start: 06/28/16 End: 06/30/16 Due: 06/30/17

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Phase: N/A Priority: Normal
NCT ID: NCT04464226 Org: User:
Start: 10/20/20 End: 06/26/28 Due: 06/26/29

EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)

Phase: N/A Priority: Normal
NCT ID: NCT04516161 Org: User:
Start: 08/03/20 End: 03/31/21 Due: 03/31/22

Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02170025 Org: User:
Start: 09/30/14 End: 09/22/17 Due: 09/22/18

A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05217914 Org: User:
Start: 07/01/22 End: 08/31/24 Due: 08/31/25

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Phase: N/A Priority: Normal
NCT ID: NCT03754660 Org: User:
Start: 01/21/19 End: 11/03/22 Due: 11/03/23

Levitra® - Real Life Safety and Efficacy of Levitra

Phase: N/A Priority: Normal
NCT ID: NCT00663598 Org: User:
Start: 10/31/03 End: 09/30/04 Due: 09/30/05

BAY73-4506 Probe Substrate Study

Phase: N/A Priority: Normal
NCT ID: NCT01287598 Org: User:
Start: 08/02/11 End: 07/30/18 Due: 07/30/19

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00439725 Org: User:
Start: 02/28/07 End: 09/30/09 Due: 09/30/10

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT00637377 Org: User:
Start: 04/30/08 End: 08/31/11 Due: 08/31/12

Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol

Phase: N/A Priority: Normal
NCT ID: NCT02170038 Org: User:
Start: 06/30/14 End: 03/31/15 Due: 03/31/16

Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study

Phase: N/A Priority: Normal
NCT ID: NCT00528112 Org: User:
Start: 08/31/07 End: 06/30/13 Due: 06/30/14

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

Phase: N/A Priority: Normal
NCT ID: NCT03603275 Org: User:
Start: 08/06/18 End: 05/14/20 Due: 05/14/21

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area

Phase: N/A Priority: Normal
NCT ID: NCT03853525 Org: User:
Start: 02/11/19 End: 03/11/19 Due: 03/11/20

Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)

Phase: N/A Priority: Normal
NCT ID: NCT04609943 Org: User:
Start: 11/24/20 End: 09/14/23 Due: 09/14/24